Randox Toxicology launches ELISA for the detection of new generation Synthetic Cannabinoids (Spice) drugs UR-144 and XLR-11
22/04/2013Leading immunoassay manufacturer Randox Toxicology has developed an ELISA targeting UR-144, XLR-11 and additional Synthetic Cannabinoid compounds which are commonly found in new ‘Spice’ and ‘K2’ blends. These emerging compounds have been rapidly introduced to the designer drug market in response to legislation banning previously identified compounds. As a result, other screening methods have since become out-dated, creating a difficult task for...